This article was originally published in The Gray Sheet
Cardiac electrophysiology product manufacturer receives second $1.6 mil. installment of $3.2 mil. debt financing from Medtronic. The funds will go towards paying off short-term bank debt and for working capital. The Mount Arlington, New Jersey firm's premarket approval application for the Alert electrophysiology system for atrial fibrillation has been granted expedited review by FDA
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.